Neuroradiology

, Volume 52, Issue 8, pp 711–721 | Cite as

The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review

Topic Article

Abstract

Voxel-based morphometry (VBM) done by means of MRI have provided new insights into the neuroanatomical basis for subjects with several conditions. Recently, VBM has been applied to investigate not only regional volumetric changes but also voxel-wise maps of fractional anisotropy (FA) computed from diffusion tensor imaging (DTI). The aim of this article is to review the recent work using VBM technique in particular focusing on schizophrenia, temporal lobe epilepsy (TLE), and Alzheimer's disease (AD)/mild cognitive impairment (MCI). In patients with schizophrenia, VBM approach detects the structural brain abnormalities that appear normal on conventional MRI. Moreover, this technique also has the potential to emerge as a useful clinical tool for early detection and monitoring of disease progression and treatment response in patients with schizophrenia or AD/MCI. In TLE, VBM approach may help elucidate some unresolved important research questions such as how recurrent temporal lobe seizures affect hippocampal and extrahippocampal morphology. Thus, in the future, large cohort studies to monitor whole brain changes on a VBM basis will lead to a further understanding of the neuropathology of several conditions.

Keywords

MRI Voxel-based morphometry Fractional anisotropy Schizophrenia Temporal lobe epilepsy Alzheimer's disease Mild cognitive impairment 

Notes

Conflict of interest statement

We declare that we have no conflict of interest.

References

  1. 1.
    Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Markesbery WR (2007) Age and gender effects on human brain anatomy: a voxel-based morphometric study in healthy elderly. Neurobiol Aging 28:1075–1087CrossRefPubMedGoogle Scholar
  2. 2.
    Pannacciulli N, Del Parigi A, Chen K, Le DS, Reiman EM, Tataranni PA (2006) Brain abnormalities in human obesity: a voxel-based morphometric study. Neuroimage 31:1419–1425CrossRefPubMedGoogle Scholar
  3. 3.
    Witte AV, Savli M, Holik A, Kasper S, Lanzenberger R (2010) Regional sex differences in grey matter volume are associated with sex hormones in the young adult human brain. Neuroimage 49:1205–1212CrossRefPubMedGoogle Scholar
  4. 4.
    Dorsaint-Pierre R, Penhune VB, Watkins KE, Neelin P, Lerch JP, Bouffard M et al (2006) Asymmetries of the planum temporale and Heschl's gyrus: relationship to language lateralization. Brain 129:1164–1176CrossRefPubMedGoogle Scholar
  5. 5.
    Valfre W, Rainero I, Bergui M, Pinessi L (2008) Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48:109–117PubMedCrossRefGoogle Scholar
  6. 6.
    May A (2006) A review of diagnostic and functional imaging in headache. J Headache Pain 7:174–184CrossRefPubMedGoogle Scholar
  7. 7.
    Brenneis C, Brandauer E, Frauscher B, Schocke M, Trieb T, Poewe W et al (2005) Voxel-based morphometry in narcolepsy. Sleep Med 6:531–536CrossRefPubMedGoogle Scholar
  8. 8.
    Yamasue H, Abe O, Kasai K, Suga M, Iwanami A, Yamada H et al (2007) Human brain structural change related to acute single exposure to sarin. Ann Neurol 61:37–46CrossRefPubMedGoogle Scholar
  9. 9.
    Lu C, Peng D, Chen C, Ning N, Ding G, Li K et al (2010) Altered effective connectivity and anomalous anatomy in the basal ganglia-thalamocortical circuit of stuttering speakers. Cortex 46:49–67CrossRefPubMedGoogle Scholar
  10. 10.
    Libon DJ, McMillan C, Gunawardena D, Powers C, Massimo L, Khan A et al (2009) Neurocognitive contributions to verbal fluency deficits in frontotemporal lobar degeneration. Neurology 73:535–542CrossRefPubMedGoogle Scholar
  11. 11.
    Wolf RC, Vasic N, Schonfeldt-Lecuona C, Ecker D, Landwehrmeyer GB (2009) Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 30:327–339CrossRefPubMedGoogle Scholar
  12. 12.
    Shibata DK (2007) Differences in brain structure in deaf persons on MR imaging studied with voxel-based morphometry. AJNR Am J Neuroradiol 28:243–249PubMedGoogle Scholar
  13. 13.
    Feldmann A, Illes Z, Kosztolanyi P, Illes E, Mike A, Kover F et al (2008) Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 23:42–46CrossRefPubMedGoogle Scholar
  14. 14.
    Ecker C, Rocha-Rego V, Johnston P, Mourao-Miranda J, Marquand A, Daly EM et al (2010) Investigating the predictive value of whole-brain structural MR scans in autism: a pattern classification approach. Neuroimage 49:44–56CrossRefPubMedGoogle Scholar
  15. 15.
    Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM (2007) Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 61:776–781CrossRefPubMedGoogle Scholar
  16. 16.
    Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE et al (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398CrossRefPubMedGoogle Scholar
  17. 17.
    Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O (2009) Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp 30:2852–2861CrossRefPubMedGoogle Scholar
  18. 18.
    Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L et al (2008) Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 70:1107–1112CrossRefPubMedGoogle Scholar
  19. 19.
    Landgrebe M, Langguth B, Rosengarth K, Braun S, Koch A, Kleinjung T et al (2009) Structural brain changes in tinnitus: grey matter decrease in auditory and non-auditory brain areas. Neuroimage 46:213–218CrossRefPubMedGoogle Scholar
  20. 20.
    Asami T, Hayano F, Nakamura M, Yamasue H, Uehara K, Otsuka T et al (2008) Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci 62:322–330CrossRefPubMedGoogle Scholar
  21. 21.
    Highley JR, Walker MA, Esiri MM, Crow TJ, Harrison PJ (2002) Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia. Cereb Cortex 12:1218–1224CrossRefPubMedGoogle Scholar
  22. 22.
    Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP et al (2003) Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 53:1075–1085CrossRefPubMedGoogle Scholar
  23. 23.
    Schmitt A, Wilczek K, Blennow K, Maras A, Jatzko A, Petroianu G et al (2004) Altered thalamic membrane phospholipids in schizophrenia: a postmortem study. Biol Psychiatry 56:41–45CrossRefPubMedGoogle Scholar
  24. 24.
    Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98:4746–4751CrossRefPubMedGoogle Scholar
  25. 25.
    Sugai T, Kawamura M, Iritani S, Araki K, Makifuchi T, Imai C et al (2004) Prefrontal abnormality of schizophrenia revealed by DNA microarray: impact on glial and neurotrophic gene expression. Ann N Y Acad Sci 1025:84–91CrossRefPubMedGoogle Scholar
  26. 26.
    Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362:798–805CrossRefPubMedGoogle Scholar
  27. 27.
    Sigmundsson T, Suckling J, Maier M, Williams S, Bullmore E, Greenwood K et al (2001) Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry 158:234–243CrossRefPubMedGoogle Scholar
  28. 28.
    Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RS, Dolan RJ (2002) Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 159:1497–1505CrossRefPubMedGoogle Scholar
  29. 29.
    Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL et al (2001) Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58:1118–1125CrossRefPubMedGoogle Scholar
  30. 30.
    Hulshoff Pol HE, Schnack HG, Mandl RC, Cahn W, Collins DL, Evans AC et al (2004) Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity. Neuroimage 21:27–35CrossRefPubMedGoogle Scholar
  31. 31.
    Marcelis M, Suckling J, Woodruff P, Hofman P, Bullmore E, van Os J (2003) Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res 122:153–167CrossRefPubMedGoogle Scholar
  32. 32.
    Spalletta G, Tomaiuolo F, Marino V, Bonaviri G, Trequattrini A, Caltagirone C (2003) Chronic schizophrenia as a brain misconnection syndrome: a white matter voxel-based morphometry study. Schizophr Res 64:15–23CrossRefPubMedGoogle Scholar
  33. 33.
    Wilke M, Kaufmann C, Grabner A, Putz B, Wetter TC, Auer DP (2001) Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. Neuroimage 13:814–824CrossRefPubMedGoogle Scholar
  34. 34.
    Shapleske J, Rossell SL, Chitnis XA, Suckling J, Simmons A, Bullmore ET et al (2002) A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex 12:1331–1341CrossRefPubMedGoogle Scholar
  35. 35.
    Paillere-Martinot M, Caclin A, Artiges E, Poline JB, Joliot M, Mallet L et al (2001) Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res 50:19–26CrossRefPubMedGoogle Scholar
  36. 36.
    Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO (2003) MRI study of white matter diffusion anisotropy in schizophrenia. NeuroReport 14:2025–2029CrossRefPubMedGoogle Scholar
  37. 37.
    Burns J, Job D, Bastin ME, Whalley H, Macgillivray T, Johnstone EC, Lawrie SM (2003) Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry 182:439–443CrossRefPubMedGoogle Scholar
  38. 38.
    Kubicki M, Park H, Westin CF, Nestor PG, Mulkern RV, Maier SE et al (2005) DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26:1109–1118CrossRefPubMedGoogle Scholar
  39. 39.
    Bullmore ET, Woodruff PW, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N et al (1998) Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophr Res 30:127–135CrossRefPubMedGoogle Scholar
  40. 40.
    Wright IC, Sharma T, Ellison ZR, McGuire PK, Friston KJ, Brammer MJ et al (1999) Supra-regional brain systems and the neuropathology of schizophrenia. Cereb Cortex 9:366–378CrossRefPubMedGoogle Scholar
  41. 41.
    Bartzokis G, Beckson M, Lu PH, Nuechterlein KH, Edwards N, Mintz J (2001) Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry 58:461–465CrossRefPubMedGoogle Scholar
  42. 42.
    Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J (2003) Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 53:412–421CrossRefPubMedGoogle Scholar
  43. 43.
    Hao Y, Liu Z, Jiang T, Gong G, Liu H, Tan L et al (2006) White matter integrity of the whole brain is disrupted in first-episode schizophrenia. NeuroReport 17:23–26CrossRefPubMedGoogle Scholar
  44. 44.
    Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS (2005) Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:587–591CrossRefPubMedGoogle Scholar
  45. 45.
    Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM (2002) Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage 17:880–889CrossRefPubMedGoogle Scholar
  46. 46.
    Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R et al (2002) Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 17:1711–1719CrossRefPubMedGoogle Scholar
  47. 47.
    Szeszko PR, Ardekani BA, Ashtari M, Kumra S, Robinson DG, Sevy S et al (2005) White matter abnormalities in first-episode schizophrenia or schizoaffective disorder: a diffusion tensor imaging study. Am J Psychiatry 162:602–605CrossRefPubMedGoogle Scholar
  48. 48.
    Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM (2005) Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res 139:229–238CrossRefPubMedGoogle Scholar
  49. 49.
    Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC et al (2007) Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res 89:12–21CrossRefPubMedGoogle Scholar
  50. 50.
    Lui S, Deng W, Huang X, Jiang L, Ma X, Chen H et al (2009) Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry 166:196–205CrossRefPubMedGoogle Scholar
  51. 51.
    Tan HY, Ang YG (2001) First-episode psychosis in the military: a comparative study of prodromal symptoms. Aust N Z J Psychiatry 35:512–519CrossRefPubMedGoogle Scholar
  52. 52.
    Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M et al (2003) Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res 60:21–32CrossRefPubMedGoogle Scholar
  53. 53.
    McGlashan TH (1988) A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 14:515–542PubMedGoogle Scholar
  54. 54.
    McGlashan TH (1998) Early detection and intervention of schizophrenia: rationale and research. Br J Psychiatry Suppl 172:3–6PubMedGoogle Scholar
  55. 55.
    Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ et al (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281–288CrossRefPubMedGoogle Scholar
  56. 56.
    Moriya J, Kakeda S, Abe O, Goto N, Yoshimura R, Hori H et al (2010) Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia. Schizophr Res 116:196–203CrossRefPubMedGoogle Scholar
  57. 57.
    Honea R, Crow TJ, Passingham D, Mackay CE (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162:2233–2245CrossRefPubMedGoogle Scholar
  58. 58.
    Lieberman JA, Phillips M, Gu H, Stroup S, Zhang P, Kong L et al (2003) Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology 28:995–1003PubMedGoogle Scholar
  59. 59.
    Whitford TJ, Grieve SM, Farrow TF, Gomes L, Brennan J, Harris AW et al (2007) Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry 164:1082–1089CrossRefPubMedGoogle Scholar
  60. 60.
    Mane A, Falcon C, Mateos JJ, Fernandez-Egea E, Horga G, Lomena F et al (2009) Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM. Schizophr Res 114:136–143CrossRefPubMedGoogle Scholar
  61. 61.
    Shin YW, Kwon JS, Ha TH, Park HJ, Kim DJ, Hong SB et al (2006) Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients. Neuroimage 30:1285–1291CrossRefPubMedGoogle Scholar
  62. 62.
    Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon DH, Pearlson GD (2008) Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr Res 98:157–162CrossRefPubMedGoogle Scholar
  63. 63.
    Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L et al (2008) Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry 165:1024–1032CrossRefPubMedGoogle Scholar
  64. 64.
    Goldstein JM, Seidman LJ, O'Brien LM, Horton NJ, Kennedy DN, Makris N et al (2002) Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry 59:154–164CrossRefPubMedGoogle Scholar
  65. 65.
    Keller SS, Roberts N (2008) Voxel-based morphometry of temporal lobe epilepsy: an introduction and review of the literature. Epilepsia 49:741–757CrossRefPubMedGoogle Scholar
  66. 66.
    Riederer F, Lanzenberger R, Kaya M, Prayer D, Serles W, Baumgartner C (2008) Network atrophy in temporal lobe epilepsy: a voxel-based morphometry study. Neurology 71:419–425CrossRefPubMedGoogle Scholar
  67. 67.
    Keller SS, Mackay CE, Barrick TR, Wieshmann UC, Howard MA, Roberts N (2002) Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage 16:23–31CrossRefPubMedGoogle Scholar
  68. 68.
    Morecraft RJ, Geula C, Mesulam MM (1992) Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J Comp Neurol 323:341–358CrossRefPubMedGoogle Scholar
  69. 69.
    Coan AC, Appenzeller S, Bonilha L, Li LM, Cendes F (2009) Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology 73:834–842CrossRefPubMedGoogle Scholar
  70. 70.
    Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMedGoogle Scholar
  71. 71.
    Braak H, Braak E (1995) Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16:271–278, discussion 278-284CrossRefPubMedGoogle Scholar
  72. 72.
    Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamashita F et al (2005) Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Neurosci Lett 382:269–274CrossRefPubMedGoogle Scholar
  73. 73.
    Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O'Brien JT, Scheltens P et al (2003) A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage 18:895–907CrossRefPubMedGoogle Scholar
  74. 74.
    Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308CrossRefPubMedGoogle Scholar
  75. 75.
    Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB et al (2008) Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med 148:427–434PubMedGoogle Scholar
  76. 76.
    Morris JC (2006) Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol 63:15–16CrossRefPubMedGoogle Scholar
  77. 77.
    Ganguli M, Dodge HH, Shen C, DeKosky ST (2004) Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 63:115–121PubMedGoogle Scholar
  78. 78.
    Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194CrossRefPubMedGoogle Scholar
  79. 79.
    Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC et al (2007) 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130:1777–1786CrossRefPubMedGoogle Scholar
  80. 80.
    Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF et al (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70:512–520CrossRefPubMedGoogle Scholar
  81. 81.
    Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V et al (2005) Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 27:934–946CrossRefPubMedGoogle Scholar
  82. 82.
    Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM (2010) Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74:113–120CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of RadiologyUniversity of Occupational and Environmental Health School of MedicineKitakyushuJapan

Personalised recommendations